SENSEX NIFTY

Religare Capital Markets

Jun 28, 2016 at 19:44 | Source: PTI
As many as three companies will come out with initial share sale to raise around Rs 17 crore this week.
Jun 28, 2016 at 14:55 | Source: CNBC-TV18
In an interview to CNBC-TV18's Mangalam Maloo and Reema Tendulkar, Ashwani Gujral of ashwanigujral.com shared his readings and outlook on market and specific stocks and Krish Subramanyam of Altamount Capital gave his outlook on F&O side of the market, specific stocks and sectors.
Jun 28, 2016 at 14:26 | Source: PTI
Staffing firm Quess Corp will hit capital markets on June 29 to raise Rs 400 crore through an initial public offering
Jun 28, 2016 at 08:10 | Source: Reuters
Endo, which has a market capitalization of USD3 billion, has been exploring several options, including an asset swap with another company, one of the sources said. The discussions are at an early stage and no transaction may occur, sources cautioned.
Jun 28, 2016 at 08:07 | Source: Reuters
It is not clear how Horizon would use the proceeds, but the move illustrates the Dublin, Ireland-based company's drive to shore up its capital and position itself for new acquisitions. Horizon has a market capitalization of USD2.4 billion (1.82 billion pounds) and a debt pile of close to USD1.3 billion.
Jun 27, 2016 at 21:59 | Source: CNBC-TV18
Ipek Ozkardeskaya, Senior Market Analyst at London Capital Group said that the political uncertainties within UK are causing further sell-off in the British market.
Jun 27, 2016 at 14:32 | Source: CNBC-TV18
In an interview to CNBC-TV18 Harendra Kumar of Elara Capital shared his reading and outlook on the market.
Jun 27, 2016 at 11:08 | Source: CNBC-TV18
The company operates amusement parks in Bengaluru, Hyderabad and Kochi and is looking to expand in 4-5 new markets in the next few years, Arun K Chittilappilly, Managing Director of Wonderla Holiday told CNBC-TV18.
Jun 27, 2016 at 09:03 | Source: CNBC-TV18
In an interview to CNBC-TV18's Sonia Shenoy & Anuj Singhal, market experts shared their readings and outlook on market technicals, fundamentals and F&O side of the market as well as specific stocks and sectors.
Jun 25, 2016 at 13:08 | Source: Reuters
Money managers were positioned relatively defensively coming into the vote, meaning they had reduced the amount of capital exposed to market turbulence, and even used the resulting sell-off as a buying opportunity, according to a report from Credit Suisse's prime brokerage division late on Friday.
Messages on Religare Capital Markets »

Web Messenger

Platinum Member

352309 Followers

Indian indices  

Source:NDTV Profit - 2:30 p.m. Tirthankar Patnaik of Religare Capital Markets says that Nifty has could run up by another 100-150 points before the fundamentals catch up. (Track stocks). All the sectoral indices, except the pharma, are trading higher. Gail India, Tech

4.55 PM Mar 6th 2014

cleverman

Platinum Member

91 Followers

Ranbaxy Labs  

also the stock will have a downside of around 10-15 per cent from these levels. We recommend a sell on the stock," adds Nangra. Arvind Bothra, Vice President, institutional research, Religare Capital Markets, says, "we expect significant negative impact on stock price following this news and reiterate

8.15 PM Jan 24th 2014

BSE/NSE Announcer

Platinum Member

14410 Followers

Crompton Greave  

"). This Advertisement should be read in conjunction with, and in continuation of, the Public Announcement (PA") published on July 04, 2013 and corrigenda to the PA published on July 16, 2013 and November 09,2013 to the shareholders of Crompton Greaves Limited ("Target Company")Religare Capital Markets Ltd

5.45 PM Jan 16th 2014

Web Messenger

Platinum Member

352309 Followers

Ipca Labs  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

352309 Followers

Glenmark  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

352309 Followers

News Now  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on market movement in 2014. ET Now: Last day of 2013, how does that really set stage for what your outlook is in the initial part

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

352309 Followers

Infosys  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on Infosys. ET Now: What makes you bullish on Infosys? Dr Tirthankar Patnaik: We are positive on the whole IT sector and therefore

3.25 PM Dec 31st 2013

DLF  

The central bank will hike repo rate, or the rate at which banks borrow from the central bank (Reserve Bank of India), by a total of 50 basis points (bps) till FY14-end, believes Tirthankar Patnaik, executive vice president- institutional sales, Religare Capital Markets. So it will sock to real

11.52 AM Oct 25th 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.47 PM Oct 23rd 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.46 PM Oct 23rd 2013

News across the web »
Mar 30, 2016 at 00:15 | Source: FirstPost
May 02, 2015 at 10:30 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.